High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers

Kristiina Iljin, Paula Vainio, Kirsi Ketola, M. Björkman, Pekka Kohonen, John Mpindi, Vidal Fey, T. Mirtti, K. Alanen, Merja Perälä, Olli Kallioniemi

    Research output: Contribution to conferenceConference articleScientific

    Original languageEnglish
    Publication statusPublished - 2010
    MoE publication typeNot Eligible
    EventBIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010 - Beijing International Convention Center, Beijing, China
    Duration: 23 Oct 201026 Oct 2010

    Conference

    ConferenceBIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010
    CountryChina
    CityBeijing
    Period23/10/1026/10/10

    Cite this

    Iljin, K., Vainio, P., Ketola, K., Björkman, M., Kohonen, P., Mpindi, J., Fey, V., Mirtti, T., Alanen, K., Perälä, M., & Kallioniemi, O. (2010). High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers. Paper presented at BIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010, Beijing, China.